FDA approves BYSANTI (milsaperidone) for Bipolar I and Schizophrenia. This dual-molecule breakthrough from Vanda Pharmaceuticals hits the market in 2026.
A new UCSF study published in 'Cell' reveals how the liver protein GPLD1 protects the aging brain by trimming toxic TNAP buildup, offering new hope for reversing cognitive decline.
The AAP has officially broken from the CDC for the first time, releasing a 2026 immunization schedule that preserves 18 routine vaccines. Here's what parents need to know.
